Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MHB, What puzzles me the MOST is why would DR. Harnoy
risk everything with filing the wrongful termination notice. He had to know that if he did this his background could be an issue. IMUN had no clue of his background that I am aware of. Now all investors as well as the medical community know about his past. Dr. Harnoy had the best keep secret since O.J Simpson. Did the Dr.really think his background would not be an issue.
Now that these cards are on the table for all to see. This will without a doubt give IMUN the better hand to play at trial. Dr. Harnoy was sitting with money in his account to do the trials in Bangkok in April. If they were successful no one would have known of his background. Instead of doing the trials in Bangkok Dr. Harnoy will be doing trials in N.Y. District court. Everyone stands to loose especially the Cancer patients.
Blackcat7717
MHB: I would love to help IMUN with a settlement. However it is out of my control now that lawyers are involved.
I hate that IMUN & ITL will be paying money to lawyers that could go towards advancing the cause for all of us. It was the Dr. who threw the first stone. IMUN was well on its way to raising more money for Dr. Harnoy. I know you have the ability to talk some sense into the Dr. He must direct his attorneys to open a dialogue with IMUN'S attorneys if there is going to be any possibly of resolving this conflict. The Dr. always spoke so passionately about saving lives. Did he not take into account what would happen when he filed a Wrongful Termination Notice. It would go a long way if Dr. Harnoy offered an olive branch and withdrew his notice and started negotiating. Then we can all focus on raising money for Cancer patients and the FDA approval not for lawyers.Please use your influence to bring everyone to the table.
Remember anything is possible:
Muhammad Ali and Joe Frazier always hugged each other after the fight.
Blackcat7717
I will be buying all day today. I told you guys before just the
shell is worth $.10 a share. This does not count any other developments that might take place in the company. Hear is were we separate the MEN from the BOYS.
Blackcat7717
Fellow investors reguarding my last post. I was tired and hungry.
however now that I had a chance to have dinner. chew on this!
IMUN is the furthest thing from a pump and dump. The company made announcements in collaboration with ITL and built a decent trading market because that is necessary to raise capital. Your stock is your most important asset when a business plan is capital intensive. And if Har Noy was so concerned about IMUN being a pump and dump, then he shouldn't have been demanding more and more money all the time. Pump and Dumps occur when there are reverse splits and misleading press releases. Nothing at all like that here. And the reason the Thai press release started a sell off, is simply because EVERY significant investor, including myself, was interested in removal of US FDA hold. That was very disappointing, FDA hold removal was what investors were looking for, Not some obscure Thai trial. And let's remember that this whole mess was started by Har Noy wrongfully terminating the License Agreement. Let's put the blame where it belongs. I'm sure Seth Shaw is working harder than anyone to rebuild value here. And he is a very smart guy, do not underestimate his ability
Blackcat7717
Dr No
I am sorry you do not know what the HE-- you are talking about.
I would bet my balls you do not own any stock.
Blackcat7717
Mhb
I am not the CEO. I might take it, however it means nothing.
Dr. Harnoy owes Set Shaw a public apology. Then an offer can be made and then Seth Shaw can make that decision as CEO. We have a great many bright an intelligent shareholders on this board. However you could not know Seth Shaw. He is a very honest and loyal man. My personal belief is Dr. Harnoy lawyer will find out very quickly that Seth Shaw did not sell a single share of stock. He received his salary in stock not cash. He purchased almost $200,000 dollars in the open market. Did Dr. Harnoy buy stock at $.10 cents and sell at .25. (maybe not)So why did the Great Dr. purchase shares in the open market or tell friends of his to buy.
Answer: He tried to take $4 million dollars from IMUN & Seth Shaw.
Blackcat7717
MHB I respectfully disagree. Where is the proof that Dr. Harnoy
offered IMUN shares in ITL. Instead it was the opposite he refused to give shares to IMUN. Show this board the letter where he offered shares to IMUN.
MHB, If you are in a position to get Dr. Harnoy to produce
results not demand money. Get him to come to the table. Have
his lawyers contact IMUN lawyers. Have him withdraw his immediate
termination notice. Have him agree to some outline of agreement. The website is down for a reason it is under construction.
Blackcat7717
Doc I thought the 10 MILLION Shares were an option @ $.10 a share.
Blackcat7717
Hello fellow investors!
Did anyone ever follow the Marriot Hotel legal dispute. The investors created World War 3 with each other. Accusations were going back and forth. When all the smoke cleared and calmer heads prevailed a settlement was made. I know everyone is bummed out right now. Stay calm let the smoke clear.
Keep in mine Dr. Harnoy & Seth did business with each other, They traveled to many presentations together and had dinner with each other many times. They became friends and business partners. Now Seth finds out his dear friend and business partner has not been totally honest with him. In fact his dear friend Dr. Harnoy is trying to ruin Seth's name and reputation to get out of his contract. Seth raised 4 Million dollars for Dr. Harnoy.
What would you do if this happened to you? What would do if you were the CEO of IMUN right now. What would you do for your shareholders? How would you create shareholder value?
Seth is doing everything he can to protect his shareholders.
I am sure we will hear from Seth & IMUN soon.
Blackcat7717
Oceanlow1 If what you say is true why did the stock tank after Dr.Harnoy announced he was going to start the trials in Bangkok. This was a clear sign to investors that he could not comply with the FDA request for whatever reason. The Dr. should have trusted Seth Shaw by explaining to him why the extended delays were taking place with the FDA. The Dr. would not allow Seth Shaw to participate on the calls with the FDA. IMUN sent Dr. Harnoy almost 4 million dollars of investors money. IMUN has to account for this money because it is a public company. Even if Dr. Harnoy can WALK on WATER he signed a contract with IMUN a public company and must still follow all the rules and regulations.
This story reminds me of a couple that are very much in LOVE. They were married on December 12,2011. He wanted to become a Doctor. She(IMUN & SETH RAISING MONEY)works 80 hours a week to put him though college. After the Doctor becomes famous(Dr. Harnoy) he no longer needs his wife (IMUN)and decides to divorce her and leave her with nothing. She (IMUN) then goes to a lawyer to recover all that she has contributed to the marriage. I cannot give you the end of this story, however all I know is that their lawyers made out very well. I believe there is still time for a reconciliation of this marriage. They can go on to raise their children Allostim & Allovax and Live Happily Ever After. THE END
Blackcat7717
Hi MHB,
It is great to hear from someone who has witnessed Allostims results first hand. Because you are familiar with the Dr's. work can you tell all of us why the Dr. did not post his results in a medical journal on the 42 patients in Carlsbad Calif.for peer review. Everyone has heard about patient #11 and the remarkable success she had with this Drug. Why wouldn't Dr. Harnoy rush to post the results in a medical journal for his peers to comment and review the data? You are a Doctor, would you not rush to publish this information? I do know these trials took place, however I have never seen any medical journal written proof on these 42 patients in Carlsbad Calif..
Blackcat7717
MHB NOW THAT IS THE WAY A POSTING SHOULD BE WRITTEN. ALL
POSITIVE WORDS.
BLACKCAT7717
To all Shareholder
Well, Well, Well, I find it hard to believe that all of you that post here are shareholders in IMUN stock. Through all the BULL---- here is where we are!
Dr Harnoy has spent 10 years in jail and he has changed his name FROM GRUENBERG TO HARNOY IN 2006 (SEE INVESTORSHUB POSTING 532 FROM JOHNNY).
Seth Shaw no years in jail and he has the same name given to him at birth.
Dr. Harnoy decides to do the trials in Bangkok Thailand. (NOW WE KNOW WHY)
Seth Shaw pushes hard for FDA hold to be lifted. Dr. Harnoy dodges Seth Shaw
With many delays regarding the lifting of FDA hold. (NOW WE KNOW WHY).
Dr. Harnoy wants to keep almost 4 million dollars from IMUN shareholders money. Dr. Harnoy has not given the shareholders anything in return. (NOW WE KNOW WHY)
Seth Shaw elects to get paid with IMUN restricted stock. He has purchased more than
$200.000 .00 dollars of IMUN stock in the open market around .24 cents. Why would Seth risk his personal money if he did not believe in the future of IMUN?
Seth Shaw posted to this board in order to give us some guidance. (Highly unusual)
Dr. Harnoy did not post to this board. (NOW WE KNOW WHY)
Seth Shaw becomes CEO on Aug. 22, 2012. Some investors hold him responsible for all decisions and actions prior to this date. He was not the CEO at that time check the 10 Q & 10 K.
If you own shares in ITL, I would be more concerned right now, however if you own IMUN shares you should be rejoicing. It is quite possible that IMUN could very well end up owning the rights and patents of ITL IP based on the currents facts. IMUN has paid Dr Harnoy almost 4 million dollars and has tarnished the reputation and the integrity of Seth Shaw and caused harm to IMUN shareholders.
If you own stock in IMUN and have bashed Seth Shaw based on fuzzy facts, it is time for an apology. We all need to back our CEO Seth Shaw. He is working around the clock for all IMUN shareholders. I believe Dr.Harnoy’s DRUG shows great promise. Dr. Harnoy still has time to resolve this matter with IMUN. If his intentions are honorable, he will come to the table to fix this.
Blackcat7717
Zal: Would you say here that this is how we separate the MEN from the BOYS.
Blackcat7717
To all Investors (including SHORT sellers)
I think it is very simple. Did you here that Tiger Woods might be getting back with his ex-wife. I think it would be easier for IMUN to get back with Dr. Har-Noy. These two individuals need to have respect for one another. They must define each others responsibilty. IMUN's job is to raise money. Dr. Har-noy's job is to find a cure for Cancer patients. It is common knowledge that the CEO bought stock on the open market at $.26. Why would he do that? An empty shell is worth more than $.05.
Blackcat7717
SCRH 8 K Jan. 14, 2013
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8658090
Blackcat7717
To all investors:
How many of you on this board have experience as a CEO
of a Public company?
Blackcat7717
SCORES RESTAURANT OPENS IN THE TAJ MAHAL IN ATLANTIC CITY.
http://www.robertsatlanticcity.com/
blackcat7717
To all Investors:
This is my theory as to why the stock is down.
There are only 2 questions that have not been answered by Dr.
Har-noy?
IMUN and Dr. Har-noy agreed to announce within 90 days after the Phase I-II were completed to publish the results on the 42 Patients in Carlsbad Calif. for pier review. This has not been done. In addition to this by now the investing community expected the FDA Hold to be lifted in full or partial and this has not been done. This would allow the Phase II- III to begin here in the U.S. not in Bangkok. Some investors did not like the Dr. choosing to start in Bangkok and refer all results to the USA & EU.
Neither of these issues have not been announced and therefore investors bailed out. Investors have no way of judging how long they might have to wait for this information to come out. If this info is announced in the near future it would draw all those investors back. The problem then at that point on them returning is there will be no major selling if this news should come out. The stock could rise rapidly to old highs.
I think the Dr. is very concerned with any delay of getting this drug to market and that is why he decided to go with Bangkok first. His concern is only to save lives. He has very little concern about the price of the stock. What the Dr. does not understand is both must work together. However when the drug is available to the public it will not matter. We will have a HUGH winner.
Blackcat7717
Abondanceinvest Tuesday, December 18, 2012 8:00:40 AM
Re: shakerzzz post# 531422 Post # of 531781
shakerzzz,UPDATE - Immunovative(IMUN-OTC) Announces Registration of Its Phase II/III Metastatic Breast Cancer Trial on ClinicalTrials.gov?
Immunovative Announces Registration of Its Phase II/III Metastatic Breast Cancer Trial on ClinicalTrials.gov
Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) announces today that Immunovative Therapies, Ltd. ("ITL") has registered its Phase II/III, randomized, placebo-controlled study in anthracycline/taxane and capecitabine pre-treated metastatic breast cancer on the ClinicalTrials.gov website. Information can be viewed by following this link: http://clinicaltrials.gov/ct2/show/NCT01741038?term=Immunovative&rank=1. The ClinicalTrials.gov Identifier number for the trial is: NCT01741038.
ClinicalTrials.gov is a Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The Web site is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Registration on the site does not imply approval or endorsement of the trial by any of these government agencies.
ITL has previously released that it has been granted regulatory clearance from Thailand authorities to advance its lead AlloStimâ„¢ immunotherapy product candidate to Phase II/III development. The details of the Study design are now available to the public on the ClinicalTrials.gov website. The primary end-point of the Study is overall survival. The study has been powered to detect a difference of 50% or greater in overall survival between the treatment and control arms. If successfully executed and the pre-defined overall survival end-point reaches statistical significance, ITL expects that the clinical data from this trial can be used to support possible marketing applications for AlloStimâ„¢ in the USA, EU and other jurisdictions. The clinical trial is scheduled for launch in April 2013. The approved AlloStimâ„¢ Phase II/III clinical trial will be conducted at the National Cancer Institute of Thailand ("NCI-Thailand") located in Bangkok, Thailand and the Principal Investigator will be Wirote Lausoontornsiri, MD, a US licensed physician that is board certified in hematology/oncology and serves as the Head of the Clinical Trials and Academic Research Unit at the NCI-Thailand.
Dr. Michael Har-Noy, CEO and founder of ITL, stated: "We are currently preparing our manufacturing and clinical operations to conduct this advanced clinical trial. Our plan is to launch this trial on or about April 2013. We are working carefully to put in place the quality assurance procedures and monitoring procedures necessary to assure the safety of the drug production, the integrity of the data and that the Study is conducted in compliance with international standards for Good Clinical Practices (GCP). The Study will have an independent Data Safety Monitoring Board (DSMB) assigned and will be regularly audited by experienced independent third party professionals."
Seth Shaw, CEO of IMUN, stated: "We are pleased with the progress ITL has made toward obtaining the necessary regulatory approvals required to launch a Phase II/III clinical study designed to test whether AlloStimâ„¢ may provide late stage, heavily pre-treated metastatic breast cancer patients with a new class of drug as a therapeutic option. We are making significant progress toward assuring that adequate financing is available for the timely launch of this trial and its flawless execution."
About Immunovative, Inc.:
On December 12th, 2011, Immunovative, Inc. ("IMUN") signed an exclusive License Agreement (the "License Agreement") with Immunovative Therapies, Ltd. ("ITL"). Under the terms of the License Agreement, IMUN has been granted an exclusive, worldwide license to commercialize any products covered under ITL's current issued and pending patent application portfolio, as well as the rights to any future patent applications, including improvements or modifications to the existing applications and any corresponding improvements or new versions of the existing products. Please visit IMUN's website at: www.imun.com.
About Immunovative Therapies, Ltd.:
Immunovative Therapies, Ltd. is an Israeli biopharmaceutical company that was founded in May 2004 with financial support from the Israeli Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world-renowned Israeli technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. ITL specializes in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for treatment of cancer and infectious disease. Please visit ITL's website at: www.immunovative.co.il
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on IMUN's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which IMUN has little or no control. Such forward-looking statements are made only as of the date of this release, and IMUN assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by IMUN with the Securities and Exchange Commission.
For more information please contact:
Mr. Seth Shaw
Chairman & Chief Executive Officer
Immunovative, Inc.
New York: +1-917-796-9926
Montreal: +1-514-840-3697
STARBUXSUX, Thank you very much for updating the board. I am
an older person and did not know how to get it change.
My investment in this company is substancial and I am in for the
long term. It is nice for the NEW investors to have the correct
information. Good Luck to all.
Blackcat7717
STARBUXSUX, Thank you very much for updating the board. I am
an older person and did not know how to get it change.
My investment in this company is substancial and I am in for the
long term. It is nice for the NEW investors to have the correct
information. Good Luck to all.
Blackcat7717
STARBUXSUX, Thank you very much for updating the board. I am
an older person and did not know how to get it change.
My investment in this company is substancial and I am in for the
long term. It is nice for the NEW investors to have the correct
information. Good Luck to all.
Blackcat7717
Thanks
Blackcat7717
Can you take care of this for the board? The web site is also wrong. It should be www.imun.com.
Blackcat7717
That was the business the shell was in before they completed
the deal with ITL. At this time it means nothing.
Blackcat7717
IMUN did a Private placement for 7 Million dollars @ $.10 or
70 Million shares. Most of those shares have been held for more than 1 year. Some investors elected to take a profit between 50%
to 100% Capital Gain at a 15% tax rate. Maybe some investors needed money for the Holiday. In either case the news is great
and this investment will be a big winner over time.
Blackcat7717
MEMORIAL DAY 2013
BLACKCAT7717
Looks like Memorial Day OPENING for SCORES in The TAJ Mahal
in Atlantic City.
Blackcat7717
Part 2 of IMUN's CEO, Mr. Seth Shaw, interview by Bob "Sully" Sullivan, host of the Big Biz Show on Nov. 9th 2012.
Watch the full video by clicking on the link below:
Video of Roberts Steakhouse Grand Open at The Taj Mahal.
http://www.atlanticcityweekly.com/casinos/features/Roberts-Steakhouse-Open-at-Taj-Mahal-178135151.html
Blackcat7717
(SCRH)Roberts Steakhouse OPENS in the Taj Mahal in Atlantic City.
Blackcat7717
Ocean is that you Bidding for 200,000 shares of IMUN @ $.259?
BID $25.9 Asked $.26
Blackcat7717
Ocean, All I can say is, all aboard.
Blackcat7717
Mr. Seth Shaw, CEO of Immunovative Inc., was interviewed by Bob "Sully" Sullivan, host of the Big Biz Show on Nov. 5th 2012.
Watch the full video by clicking on the link below; the segment starts at the 2:16 mark.
Deal flow Conference cancelled in NYC because of Hurricane Sandy.
I future date will be announced.
Blackcat7717
Things are quiet for now.Waiting for the
next 3 quarters to be posted. How can I go wrong at these prices.
I am not looking for much, just 1000 per cent in a year.
I just bought 100,000 shares of SCRH @ .04. Cannot get any quanity
at these prices.
Blackcat7717
We need 3 more quarterly filings and we will be current and on our way.
Blackcat7717
Hello all Investors, This is just my opinion. The stock traded at $.31 yeaterday. The 52 week high is $.32.4 this opens the door to some SHORT selling. It is good to shake the tree and have the stock correct itself. Many other Bio stocks are down today. It would be nice if IMUN holds around $.25. Happy investing!
Blackcat7717
Form 4 INSIDER BUYING from the CEO filed at 4 different times this month. Guess he thinks it a buy.
Blackcat7717